Article
Technology insight: therapy for Duchenne muscular dystrophy-an opportunity for personalized medicine?
Nature clinical practice. Neurology - 1 Mar 2008
Lim Leland E, Rando Thomas A
Abstract excerpt
Since the identification of dystrophin as the protein product of the Duchenne and Becker muscular dystrophy locus, many different mutations, encompassing the entire spectrum of gene mutations ranging from point mutations to large deletions, have been found. These discoveries have led to the inves...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
